The differential effects of statins on the metastatic behaviour of prostate cancer

BACKGROUND: Although statins do not affect the incidence of prostate cancer (CaP), usage reduces the risk of clinical progression and mortality. Although statins are known to downregulate the mevalonate pathway, the mechanism by which statins reduce CaP progression is unknown. METHODS: Bone marrow s...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, M, Hart, C, Tawadros, T, Ramani, V, Sangar, V, Lau, M, Clarke, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349174/
https://www.ncbi.nlm.nih.gov/pubmed/22531631
http://dx.doi.org/10.1038/bjc.2012.138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349174/
https://www.ncbi.nlm.nih.gov/pubmed/22531631
http://dx.doi.org/10.1038/bjc.2012.138

Ejemplares similares